BOS, V.; CROUWEL, F.; WAAIJENBERG, P.; BOUMA, G.; DUIJVESTEIN, M.; BUITER, H.; BRAND, H.; HAMER, H.; DE BOER, N. Salivary Calprotectin Is not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases, v. 31, n. 3, p. 283-289, 15 set. 2022.